Post-approval studies (Phase 4)UnknownNCT05075044
What this trial is testing
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV Infected
Who this might be right for
HIV InfectionsCOVID-19
China National Biotec Group Company Limited 400